Clinical experience reversing factor Xa inhibitors with four-factor prothrombin complex concentrate in a community hospital

類似資料

• Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
  著者:: Rech, Megan A., 等
  出版事項: (2021)
• Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro
  著者:: Herm Jan M. Brinkman, 等
  出版事項: (2022-03-01)
• Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
  著者:: Tao, Jing, 等
  出版事項: (2018)
• Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
  著者:: Lu, Genmin, 等
  出版事項: (2020)
• Use and outcomes of prothrombin complex concentrate for factor Xa inhibitor-associated bleeding
  著者:: Frank, Annabel K., 等
  出版事項: (2020)